Congratulations (paper published)

Congratulations to our members for their recent publication. Droxidopa has been approved for the treatment of neurogenic orthostatic hypotension (NOH) under the US Food and Drug Administration accelerated approval program, which warrants confirmatory evidence on long-term efficacy of droxidopa. Hereby, we synthesize evidence from published randomized controlled trials about the safety and efficacy of droxidopa for patients with neurogenic orthostatic hypotension. This paper has been published in the Journal of Clinical Autonomic Research @Springer (IF=1.5) one of the world leading journals in autonomic disorders.

URL: http://www.ncbi.nlm.nih.gov/pubmed/26951135

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s